Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
about
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival.TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.A novel germline PALB2 deletion in Polish breast and ovarian cancer patientsAn identical, complex TP53 mutation arising independently in two unrelated families with diverse cancer profiles: the complexity of interpreting cancer risk in carriers.The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomasp19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.Histological profile and age at diagnosis of breast and ovarian tumors: A register-based study in Espirito Santo, Brazil.The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern.
P2860
Q27320720-C1FCF9F4-1772-4D70-B1E1-7E2DB992E73EQ33317044-97A73FC7-9218-4A5F-B6CD-D57894A76A6BQ33528298-71ED7603-0A03-400F-8089-04770247D756Q36143087-E8CF9730-98E8-4773-A20C-71E73F35382EQ36685531-339F24F1-8960-49D5-82C1-7CB15CE0DA91Q37005057-DEAE5D2B-CDC9-4BB8-91C3-50DE328A5125Q37435376-771450AD-C49B-43F5-A551-2384557F9AA6Q37589242-AD7617AC-6FBC-4E2A-A1F3-69FD81B182EFQ37641094-9A7E74C3-A9DC-4043-A907-0573D60DE55CQ37687176-83C05655-8A35-4F56-A81D-2F0320BAEAFCQ38407182-28C850C6-D4CE-4228-9340-F7F3C834B0C8Q50955323-B800DDD7-0119-4B2A-9221-D8FD55E3CE17
P2860
Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
@en
Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
@nl
type
label
Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
@en
Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
@nl
prefLabel
Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
@en
Geographical variations in TP53 mutational spectrum in ovarian carcinomas.
@nl
P2860
P1476
Geographical variations in TP53 mutational spectrum in ovarian carcinomas
@en
P2093
Kraszewska E
P2860
P304
P356
10.1111/J.1469-1809.2006.00257.X
P407
P577
2006-09-01T00:00:00Z